153 related articles for article (PubMed ID: 22899222)
1. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
3. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
[TBL] [Abstract][Full Text] [Related]
4. GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers.
Moskalev EA; Jandaghi P; Fallah M; Manoochehri M; Botla SK; Kolychev OV; Nikitin EA; Bubnov VV; von Knebel Doeberitz M; Strobel O; Hackert T; Büchler MW; Giese N; Bauer A; Muley T; Warth A; Schirmacher P; Haller F; Hoheisel JD; Riazalhosseini Y
Oncotarget; 2015 Feb; 6(6):4418-27. PubMed ID: 25557172
[TBL] [Abstract][Full Text] [Related]
5. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
7. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
[TBL] [Abstract][Full Text] [Related]
8. [Novel methylation and expression markers associated with breast cancer].
Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.
Kwon MS; Kim SJ; Lee SY; Jeong JH; Lee ES; Kang HS
Oncol Rep; 2006 Jan; 15(1):27-32. PubMed ID: 16328031
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
13. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Fourkala EO; Hauser-Kronberger C; Apostolidou S; Burnell M; Jones A; Grall J; Reitsamer R; Fiegl H; Jacobs I; Menon U; Widschwendter M
Breast Cancer Res Treat; 2010 Apr; 120(2):345-55. PubMed ID: 19353266
[TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
16. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
17. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract][Full Text] [Related]
18. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
